Table 1.

Comparisons of clinical characteristics between NACT outcome groups

Predicted worse (N = 23)Predicted Better (N = 34)Pa
Age
 Mean (SD)59.9 (14.7)61.7 (11.8)0.79
BMI
 Mean (SD)24.0 (5.3)27.0 (6.7)0.11
Germline BRCA mutated
 Yes380.50
 No2026
Stage
 3C18271
 457
Debulking
 Complete10190.06
 <5 mm512
 >5 mm83
CA125 Reduction (%)
 Mean (SD)83.9 (23.7)88.0 (18.2)0.61
Line 1 Regimen
 Platinum-based23341
 Other00
Line 1 Response
 Complete16280.30
 Partial24
 Stable42
 Progressive10
Line 1 Platinum Resistant
 Yes1290.057
 No1125
Line 2 Regimen
 None550.63
 Platinum-based918
 Other911
Line 2 Response
 Not applicable550.16
 Complete814
 Partial06
 Stable86
 Progressive23
Line 2 Platinum Resistant
 Yes850.0044
 No113
Line 3 Regimen
 Not applicable10130.14
 platinum-based718
 Other63
Line 3 Response
 Complete040.63
 Partial47
 Stable89
 Progressive11
Line 3 Platinum Resistant
 Yes7150.53
 No03
  • aP value calculated by Fisher's exact test or Wilcoxon rank-sum test.